Last update 23 Jan 2025

Swedish Orphan Biovitrum Japan Co., Ltd.

Subsidiary Company|
Japan

Overview

Tags

Immune System Diseases
Hemic and Lymphatic Diseases
Congenital Disorders
Synthetic peptide
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases2
Hemic and Lymphatic Diseases2
Neoplasms1
Top 5 Drug TypeCount
Synthetic peptide1
Small molecule drug1
Top 5 TargetCount
C3(Complement C3)1
TPO receptor(Thrombopoietin receptor)1

Related

2
Drugs associated with Swedish Orphan Biovitrum Japan Co., Ltd.
Pegcetacoplan
Target
C3
Mechanism
C3 inhibitors
Active Org.
Apellis Pharmaceuticals, Inc.Apellis Pharmaceuticals, Inc. [+4]
Originator Org.
Apellis Pharmaceuticals, Inc.Apellis Pharmaceuticals, Inc.
Active Indication
Geographic Atrophy [+10]
Inactive Indication
Amyotrophic Lateral Sclerosis [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date14 May 2021
Avatrombopag Maleate
Target
TPO receptor
Mechanism
TPO receptor agonists
Active Org.
Swedish Orphan Biovitrum Pty Ltd. [+6]
Originator Org.
Astellas Pharma, Inc.Astellas Pharma, Inc.
Active Indication
Chronic liver disease [+3]
Inactive Indication
Cardiovascular Diseases [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date21 May 2018
1
Clinical Trials associated with Swedish Orphan Biovitrum Japan Co., Ltd.
JPRN-UMIN000050211
/ CompletedNot Applicable
THE CLINICAL, HUMANISTIC, AND ECONOMIC BURDEN AMONG PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN JAPAN - THE CLINICAL, HUMANISTIC, AND ECONOMIC BURDEN AMONG PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN JAPAN
100 Clinical Results associated with Swedish Orphan Biovitrum Japan Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Swedish Orphan Biovitrum Japan Co., Ltd.
Login to view more data
100 Deals associated with Swedish Orphan Biovitrum Japan Co., Ltd.
Login to view more data
100 Translational Medicine associated with Swedish Orphan Biovitrum Japan Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pegcetacoplan
 ( C3 )		Hemoglobinuria, Paroxysmal
More
Approved
Avatrombopag Maleate
 ( TPO receptor )		Thrombocytopenia
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free